Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study.

Lixin WangJianmin LuoGuofeng ChenMeiyun FangXudong WeiYinghua LiZhuogang LiuYin ZhangSujun GaoJianliang ShenXin WangXiaoning GaoWei ZhouYigai MaHui LiuXinquan LiLinhua YangKai SunLiping Dou

Published in: Clinical epigenetics (2020)

Clinical Trials, NCT02886559 . Registered 01 September 2016.

Keyphrases

acute myeloid leukemia
clinical trial
open label
double blind
phase ii
peripheral blood
allogeneic hematopoietic stem cell transplantation
placebo controlled
phase iii
recombinant human
study protocol
acute lymphoblastic leukemia
randomized controlled trial
low dose
diffuse large b cell lymphoma
high dose